Drug diversion is a concept involving the transfer of any legally prescribed controlled substance from the individual for whom it was prescribed to another person for any illicit use. According to the Centers for Disease Control and Prevention (CDC), drug diversion can result in several types of patient harm, including substandard care delivered by an impaired healthcare provider, denial of essential pain medication or therapy, and risk of infection.
In this video interview, Kara Earle, senior drug diversion specialist at data protection and governance provider, FairWarning, and Lisa Polinsky, assistant vice president, pharmacy services at the Maryland-based LifeBridge Health, discuss the challenges that drug diversion presents for healthcare organizations.
Tune in to hear these experts' insights for identifying and remediating drug diversion cases, the steps for establishing robust drug diversion monitoring programs at patient care facilities, and more.
